https://www.youtube.com/watch?v=WPPprmwn6T0 Watch this video of Clarify Health’s President, Todd Gottula, to hear him discuss how to accelerate adoption of value-based care at the AWS booth. He described five pillars [...]
The FDA’s latest draft guidance on diversity and inclusion in clinical trials Diversity within the US continues to grow, with four in 10 Americans identifying with a race or ethnic [...]
pGHD is a medical condition that affects a child’s puberty and physical development. Somatropin injections are used to treat pGHD, improve growth in childhood, and prevent or improve metabolic impairments [...]
The pandemic underlined the industry-wide urgency to modernize the nation’s health system infrastructure and the necessity to adopt value-based contracts to improve outcomes. Systems of intelligence are poised to drive [...]
Pfizer partnered with Clarify Health for a real-world study assessing medication adherence to tafamidis among patients with heart disease caused by transthyretin amyloid cardiomyopathy (ATTR-CM). The study titled “Baseline Characteristics [...]